What is the current Carotid Stents market size?

The Carotid Stents market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Carotid Stents market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Carotid Stents market?

Increasing demand for minimally invasive procedures drives the Carotid Stents market.

What are the major challenges facing the Carotid Stents market?

Stringent regulatory requirements pose significant challenges to the market.

Which regions are the leaders in the Carotid Stents market?

North America and Europe are the leading regions in the Carotid Stents market.

Who are the top companies in the Carotid Stents market?

Top companies include Medtronic, Boston Scientific, and Abbott Laboratories.

What are the future opportunities in the Carotid Stents market?

Emerging markets and technological advancements offer future outlook opportunities.

How does technology impact the Carotid Stents market?

Advances in stent technology improve patient outcomes and drive market growth.

What is the current regulatory landscape for the Carotid Stents market?

The regulatory landscape is governed by FDA and CE mark approvals.

What is the future outlook for the Carotid Stents market?

The future outlook is positive with increasing adoption of carotid stenting procedures.

Carotid Stents Growth Trends & Strategic Outlook 2033

Carotid Stents by Application (Ambulatory Surgical Units, Hospitals, Clinics, Others), by Types (Balloon Expandable Stents, Self-Expanding Stents), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $1866.6 million

CAGR: 9.6%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $1866.6 million

CAGR: 9.6%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Carotid Stents Market Size | CAGR 9.6% Forecast 2033

Carotid Stents Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $1866.6 million

CAGR: 9.6%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $1866.6 million

CAGR: 9.6%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Carotid Stents Market Overview

The Carotid Stents market refers to the industry involved in the development, manufacturing, and distribution of carotid stents, which are medical devices used to treat carotid artery disease. As the global population ages and the prevalence of cardiovascular diseases increases, the Carotid Stents market size is expected to experience significant growth outlook, with a promising market forecast and substantial industry expansion. The scope of this market encompasses various types of carotid stents, including bare-metal stents, drug-eluting stents, and covered stents, catering to diverse patient needs and preferences. According to recent estimates, the current Carotid Stents market size is approximately $1.3 billion, with a projected growth forecast of 7.5% Compound Annual Growth Rate (CAGR) during the forecast period from 2026 to 2033. Key drivers of this growth include advancements in technology shifts, evolving regulations, and changing consumer behavior.

Loading chart…

The Carotid Stents market is influenced by several key forces, including competitive intensity, supply-chain dynamics, and regulatory frameworks. The largest region in the Carotid Stents market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific, driven by increasing healthcare expenditure and growing awareness about cardiovascular diseases. As the market continues to evolve, stakeholders must stay informed about the latest market trends, industry developments, and growth opportunities to maintain a competitive edge in the global Carotid Stents market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.87 billion
Revenue forecast in 2033	3.26 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Boston Scientific; Medtronic; Terumo; Balton; InspireMD; Optimed; W. L. Gore & Associates
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Carotid Stents market is poised for significant growth, driven by factors such as the increasing prevalence of carotid artery disease and the growing demand for minimally invasive procedures. The Carotid Stents market size is expected to expand substantially over the forecast period, with a growth forecast that is promising for industry stakeholders.

Growth Drivers2 items

Advances in stent technology, including the development of drug-eluting stents, are driving the adoption of carotid stenting procedures, contributing to the growth of the Carotid Stents market.

The rising incidence of stroke and other cardiovascular diseases is fueling the demand for carotid stents, leading to an increase in the Carotid Stents market size.

Restraints2 items

Stringent regulatory requirements and high costs associated with carotid stenting procedures are limiting the growth of the Carotid Stents market, making it challenging for new entrants to penetrate the market.

The availability of alternative treatment options, such as carotid endarterectomy, is also hindering the growth of the Carotid Stents market, as some patients may opt for these alternatives over stenting procedures.

Opportunities2 items

The increasing demand for minimally invasive procedures in emerging economies presents a significant opportunity for growth in the Carotid Stents market, driving the adoption of carotid stenting procedures.

The development of novel stent materials and designs is expected to further drive the growth of the Carotid Stents market, as these advancements will improve the efficacy and safety of carotid stenting procedures.

Challenges2 items

The Carotid Stents market faces challenges related to reimbursement and insurance coverage, as the high costs of carotid stenting procedures can be a barrier to adoption.

The need for skilled healthcare professionals to perform carotid stenting procedures is also a challenge, as the lack of trained professionals can limit the growth of the Carotid Stents market.

Market Segmentation

Loading chart…

The Application segment in the Carotid Stents market refers to the different uses of carotid stents in various medical procedures. This segment contributes to the overall Carotid Stents market size by providing insights into the demand for carotid stents in different applications, such as treating carotid artery disease and preventing stroke. Understanding the application segment is crucial for market players to develop targeted strategies and products that cater to specific medical needs, ultimately driving the growth of the Carotid Stents market. The Carotid Stents segmentation by application provides valuable insights into the market taxonomy.

The Types segment in the Carotid Stents market encompasses various subtypes of carotid stents, including [object Object] and [object Object]. This segment plays a significant role in determining the overall Carotid Stents market size by highlighting the demand for different types of carotid stents. Each subtype has its own set of characteristics, advantages, and disadvantages, which influence the purchasing decisions of medical professionals and patients. By analyzing the types segment, market players can identify opportunities to develop innovative products that address specific needs, such as improved stent design and enhanced biocompatibility. The types segment is a critical component of the Carotid Stents market taxonomy, enabling market players to navigate the complex landscape of carotid stent products.

Carotid Stents Segmentation Breakdown8 items

Application

Ambulatory Surgical Units

Hospitals

Clinics

Others

Types

Balloon Expandable Stents

Self-Expanding Stents

Regional Insights

Loading chart…

The Carotid Stents market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of carotid stents, favorable policies, and significant investments in healthcare infrastructure. Key drivers for North America include a mature ecosystem, high demographics of cardiovascular diseases, and advanced infrastructure.

In Europe, key drivers include a high adoption rate of carotid stents, favorable policies and investments in healthcare, and a mature ecosystem. Asia Pacific's growth is driven by increasing demographics of cardiovascular diseases, improving infrastructure, and rising adoption of carotid stents. Latin America and Middle East & Africa are expected to witness moderate growth, driven by increasing investments in healthcare and rising adoption of carotid stents. The regional forecast indicates a positive outlook for the Carotid Stents market, with opportunities for growth and expansion in various regions.

Competitive Landscape

The Carotid Stents market is moderately consolidated, driven by a mix of global players and local companies. The Carotid Stents competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies emphasize regional expansion and localization.

Companies in the Carotid Stents market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies focus on technological advancements, service model innovation, and channel strength. The following companies have adopted distinct strategies:

Abbott: regional expansion

Boston Scientific: premium pricing

Medtronic: innovation pipeline

Terumo: local manufacturing

InspireMD: OEM tie-ups

W. L. Gore & Associates: vertical integration

Key Carotid Stents Companies8 items

Abbott

Boston Scientific

Medtronic

Terumo

Balton

InspireMD

Optimed

W. L. Gore & Associates

Market Ecosystem

The Carotid Stents ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of carotid stents, with each segment influencing the overall efficiency and effectiveness of the ecosystem. A thorough value chain analysis is essential to understanding the complex interactions within the Carotid Stents ecosystem.

Raw material suppliers — providing metals and polymers

OEMs / manufacturers — designing and producing stents

Technology providers — developing new stent technologies

Distributors / channel partners — delivering stents to healthcare facilities

Service providers / after-sales — offering training and support

End users / buyers — healthcare professionals and institutions

Regulators/standards bodies — establishing safety and efficacy standards

The flow of value within the Carotid Stents ecosystem is influenced by various control points, including regulatory approvals, technological advancements, and partnerships between manufacturers and healthcare providers. Dependency risks arise from input constraints, such as the availability of high-quality raw materials, and standards set by regulatory bodies. Switching costs and interoperability requirements also impact the ecosystem, as healthcare institutions may be limited in their ability to switch between different stent manufacturers. Furthermore, regional differences in healthcare infrastructure and regulatory frameworks can affect the Carotid Stents ecosystem, leading to variations in adoption and usage patterns across different regions.

Recent Industry Insights

The Carotid Stents industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product portfolios and expanding geographical reach. Notable mergers and acquisitions have also taken place, aiming to strengthen market positions and drive innovation. Furthermore, several product and technology launches have been observed, emphasizing improved stent design, biocompatibility, and minimally invasive procedures. Regulatory changes have also played a crucial role, with updates on labeling and approval processes. A shift in consumer preferences towards minimally invasive treatments has been observed, driving the demand for advanced carotid stents. Additionally, funding rounds and expansions have been secured by various companies to support research and development in this field.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Carotid Stents market outlook. The market attractiveness is moderate, driven by the increasing prevalence of carotid artery disease and advancements in stent technology. The competitive intensity is high, with key players investing heavily in research and development to improve stent design and functionality. The long-term outlook is promising, with the market expected to grow steadily over the next five years.

The innovation landscape is evolving rapidly, with a focus on developing more effective and safer stents. The demand-supply balance is stable, with manufacturers meeting the growing demand for carotid stents. However, key risk factors such as regulatory changes and reimbursement issues may impact market growth. Overall, the Carotid Stents market presents opportunities for growth and innovation, but players must navigate the complex landscape to succeed.

11 items

1. Executive Summary

2. Carotid Stents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Carotid Stents Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Carotid Stents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Ambulatory Surgical Units

6.1.2. Hospitals

6.1.3. Clinics

6.1.4. Others

6.2. Global Carotid Stents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Balloon Expandable Stents

6.2.2. Self-Expanding Stents

6.3. Global Carotid Stents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Carotid Stents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Carotid Stents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Carotid Stents Market Competition by Key Manufacturers

8.1. Global Carotid Stents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Carotid Stents: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boston Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Medtronic

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Balton

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. InspireMD

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Optimed

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. W. L. Gore & Associates

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Carotid Stents Market

Figure 4: Global Carotid Stents Market: Drivers

Figure 5: Global Carotid Stents Market: Challenges

Figure 6: Global Carotid Stents Market: Trends

Figure 7: Global Carotid Stents Market: Opportunity

Figure 8: Global Carotid Stents Market: Restraint

Figure 9: Global Carotid Stents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Carotid Stents Market Value (USD Million) By Region

Figure 15: Global Carotid Stents Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Carotid Stents Market Value (USD Million) By Region

Figure 23: Global Carotid Stents Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Carotid Stents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Carotid Stents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Carotid Stents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Carotid Stents Market Value (USD Million) By Region

Table 10: Global Carotid Stents Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Carotid Stents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Carotid Stents Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Carotid Stents Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: Boston Scientific Basic Information And Sales Area

Table 33: Boston Scientific. Products Portfolio

Table 34: Medtronic Basic Information And Sales Area

Table 35: Medtronic. Products Portfolio

Table 36: Terumo Basic Information And Sales Area

Table 37: Terumo. Products Portfolio

Table 38: Balton Basic Information And Sales Area

Table 39: Balton. Products Portfolio

Table 40: InspireMD Basic Information And Sales Area

Table 41: InspireMD. Products Portfolio

Table 42: Optimed Basic Information And Sales Area

Table 43: Optimed. Products Portfolio

Table 44: W. L. Gore & Associates Basic Information And Sales Area

Table 45: W. L. Gore & Associates. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Carotid Stents Market Value (USD Million) By Region

Table 51: Global Carotid Stents Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Carotid Stents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.87 billion
Revenue forecast in 2033	3.26 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Boston Scientific; Medtronic; Terumo; Balton; InspireMD; Optimed; W. L. Gore & Associates
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options